274 related articles for article (PubMed ID: 34048162)
1. Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis.
Sasidharanpillai S; Ravishankar N; Kamath V; Bhat PV; Bhatt P; Arunkumar G
Asian Pac J Cancer Prev; 2021 May; 22(5):1351-1364. PubMed ID: 34048162
[TBL] [Abstract][Full Text] [Related]
2. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
Balachandra S; Kusin SB; Lee R; Blackwell JM; Tiro JA; Cowell LG; Chiang CM; Wu SY; Varma S; Rivera EL; Mayo HG; Ding L; Sumer BD; Lea JS; Bagrodia A; Farkas LM; Wang R; Fakhry C; Dahlstrom KR; Sturgis EM; Day AT
Cancer; 2021 Mar; 127(6):850-864. PubMed ID: 33270909
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
4. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
[TBL] [Abstract][Full Text] [Related]
5. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
7. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
de Martel C; Plummer M; Vignat J; Franceschi S
Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human papillomavirus DNA and p16
Olesen TB; Sand FL; Rasmussen CL; Albieri V; Toft BG; Norrild B; Munk C; Kjær SK
Lancet Oncol; 2019 Jan; 20(1):145-158. PubMed ID: 30573285
[TBL] [Abstract][Full Text] [Related]
9. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genotype distribution of human papillomavirus infection in different anatomical sites among men who have sex with men: A systematic review and meta-analysis.
Farahmand M; Monavari SH; Tavakoli A
Rev Med Virol; 2021 Nov; 31(6):e2219. PubMed ID: 33527636
[TBL] [Abstract][Full Text] [Related]
11. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
12. HPV-related cancers after solid organ transplantation in the United States.
Madeleine MM; Finch JL; Lynch CF; Goodman MT; Engels EA
Am J Transplant; 2013 Dec; 13(12):3202-9. PubMed ID: 24119294
[TBL] [Abstract][Full Text] [Related]
13. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
de Sanjosé S; Bruni L; Alemany L
Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.
Tsikis S; Hoefer L; Charnot-Katsikas A; Schneider JA
Eur J Cancer Prev; 2016 Nov; 25(6):558-71. PubMed ID: 26628088
[TBL] [Abstract][Full Text] [Related]
15. Updating the natural history of human papillomavirus and anogenital cancers.
Moscicki AB; Schiffman M; Burchell A; Albero G; Giuliano AR; Goodman MT; Kjaer SK; Palefsky J
Vaccine; 2012 Nov; 30 Suppl 5(0 5):F24-33. PubMed ID: 23199964
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic human papillomavirus vaccines: past, present and future.
Anderson LA
Pathology; 2012 Jan; 44(1):1-6. PubMed ID: 22157686
[TBL] [Abstract][Full Text] [Related]
17. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
[TBL] [Abstract][Full Text] [Related]
18. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
19. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic burden of HPV-related cancers in the US veteran population.
Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
